San Francisco, CA, United States of America

Cyd Johnson

This inventor holds 1 USPTO granted patent. Top assignee: University of Virginia Patent Foundation. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cyd Johnson - Innovator in Autoimmune Disease Treatment

Introduction

Cyd Johnson is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of autoimmune disease treatment through her innovative research and patent work. Her dedication to advancing medical science is evident in her groundbreaking inventions.

Latest Patents

Cyd Johnson holds a patent for "Antigen-based heteropolymers and method for treating autoimmune diseases." This patent describes constructs consisting of antigen-based heteropolymers (AHP's) that include at least one monoclonal antibody specific for binding to the complement receptor (CR1) site on human or non-human primate erythrocytes. The anti-CR1 monoclonal antibody is crosslinked to an antigen specific for a target pathogenic autoantibody. The patent also outlines a method for treating autoimmune diseases in humans or non-human primates using the AHP.

Career Highlights

Cyd Johnson is associated with the University of Virginia Patent Foundation, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating autoimmune diseases, showcasing her commitment to improving patient outcomes.

Collaborations

Cyd has collaborated with notable colleagues, including Edward N Martin, Jr and Craig J Reist. These partnerships have further enhanced her research and contributed to the advancement of her innovative ideas.

Conclusion

Cyd Johnson's contributions to the field of autoimmune disease treatment through her patent work exemplify her role as a leading inventor. Her innovative approach and dedication to research continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…